Abstract
Some cellular and molecular features of chronic lymphocytic leukaemia (CLL) cells that are associated with prognosis may reflect the context within which their progenitors encountered antigen. It follows that the nature of antigen drive in CLL could influence the clinical course and we were prompted to assess the impact, if any, of affinity maturation (an antigen-driven process) on prognosis. Statistical models for assessing affinity maturation status are typically applied to VH gene sequence data analysed using a web-based resource like IMGT or VBASE. Since these resources differ with respect to some key relevant features, we evaluated a cohort of CLL cases by applying statistical models to VH data derived from both IMGT and VBASE. Important differences between the resulting data sets became apparent. These resulted from database variance and because IMGT and VBASE define complementarity-determining and framework regions (CDRs, FRs) in different ways. Thus, the numbers of mutations identified and their distribution between CDRs/FRs varied between the data sets for the majority of clones. Consequently, two different but overlapping sets of cases with evidence of affinity maturation were defined. Notwithstanding their differences, no significant associations of affinity maturation status with CD38 expression, p53 functional status or survival were identifiable in either data set.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rozman C, Montserrat E . Chronic lymphocytic leukaemia. N Engl J Med 1995; 333: 1052–1057.
Caligaris-Capio F, Hamblin TJ . B-cell chronic lymphocytic leukaemia: a bird of a different feather. J Clin Oncol 1999; 17: 399–408.
Lin K, Sherrington PD, Dennis M, Matrai Z, Cawley JC, Pettitt AR . Relationship between p53 dysfunction, CD38 expression, and IgVH mutation in chronic lymphocytic leukaemia. Blood 2002; 100: 1404–1409.
Matrai Z, Lin K, Dennis M, Sherrington P, Zuzel M, Pettitt AR et al. CD38 expression and IgVH gene mutation in B-cell chronic lymphocytic leukemia. Blood 2001; 97: 1902.
Damle RN, Wasil T, Fais F . Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847.
Ibrahim S, Keating M, Do KA, O'Brien S, Huh YO, Jilani I et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001; 98: 181–186.
Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854.
Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177–1184.
Neuberger MS, Ehrenstein MR, Rada C, Sale J, Batista FD, Williams G et al. Memory in the B-cell compartment: antibody affinity maturation. Philos Trans R Soc London B 2000; 355: 357–360.
Schroder AE, Greiner A, Seyfert C, Berek C . Differentiation of B cells in the nonlymphoid tissue of the synovial membrane in patients with rheumatoid arthritis. Proc Natl Acad Sci USA 1996; 93: 221–225.
Matsumoto M, Lo SF, Carruthers CJL, Min J, Mariathasan S, Huang G et al. Affinity maturation without germinal centres in lymphotoxin-α-deficient mice. Nature 1996; 382: 462–466.
Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998; 102: 1515–1525.
Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X et al. Relation of gene expression phenotype to iummunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001; 194: 1639–1647.
Klein U, Tu Y, Stolovitzky GA, Keller JL, Haddad Jr J, Miljkovic V et al. Transcriptional analysis of the B cell germinal centre reaction. Proc Natl Acad Sci USA 2003; 100: 2639–2644.
Damle RN, Ghiotto F, Valetto A, Albesiano E, Fais F, Yan XJ et al. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 2002; 99: 4087–4093.
Chiorazzi N, Ferrarini M . B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003; 21: 841–894.
Chang B, Casali P . The CDR1 sequences of a major proportion of human germline Ig VH genes are inherently susceptible to amino acid replacement. Immunol Today 1994; 15: 367–373.
Wagner SD, Neuberger MS . Somatic hypermutation of immunoglobulin genes. Annu Rev Immunol 1996; 14: 441–457.
Keppler TB . Codon bias and plasticity in immunoglobulins. Mol Biol Evol 1997; 14: 637–643.
Lossos IS, Tibshirani R, Narasimhan B, Levy R . The inference of antigen selection on Ig genes. J Immunol 2000; 165: 5122–5126.
Dörner T, Brezinschek H-P, Brezinschek RI, Foster SJ, Domiati-Saad R, Lipsky PE . Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol 1997; 158: 2779–2789.
Dyer MJS, Oscier DG . The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia. Leukemia 2002; 16: 973–984.
Lefranc M-P . IMGT, the international ImMunoGeneTics database®. Nucleic Acids Res 2003; 31: 307–310.
Chothia C, Lesk AM, Gherardi E, Tomlinson IM, Walter G, Marks JD et al. Structural repertoire of the human VH segments. J Mol Biol 1992; 227: 799–817.
Tomlinson IM, Cox JP, Gherardi E, Lesk AM, Chothia C . The structural repertoire of the human Vκ . EMBO J 1995; 14: 4628–4638.
Williams SC, Frippiat J-P, Tomlinson IM, Ignatovich O, Lefranc M-P, Winter G . Sequence and evolution of the human germline Vλ repertoire. J Mol Biol 1996; 264: 220–232.
Kabat E, Wu T, Reid-Miller M, Perry H, Gottesman K . Sequences of Proteins of Immunological Interest, Public Health Service National Institutes of Health, US Department of Health and Human Services 1991. Bethesda Maryland, USA.
Lefranc M-P . The IMGT unique numbering for immunoglobulins, T cell receptors and Ig-like domains. Immunologist 1999; 7: 132–136.
Lin K, Manocha S, Harris RJ, Matrai Z, Sherrington PD, Pettitt AR . High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3–21 gene segment. Blood 2003; 102: 1145–1146.
Davis ZA, Orchard JA, Corcoran MM, Oscier DG . Divergence from the germ-line sequence in unmutated chronic lymphocytic leukemia is due to somatic mutation rather than polymorphisms. Blood 2003; 102: 3075.
Forconi F, Sahota SS, Lauria F, Stevenson FK . Revisiting the definition of somatic mutational status in B-cell tumors: does 98% homology mean that a VH-gene is mutated? Leukemia 2004; 18: 882–883.
Hans-Helmar A, Werner M (http://www.dnaplot.de).
Pettitt AR, Sherrington PD, Stewart G, Cawley JC, Taylor AM, Stankovic T . p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation. Blood 2001; 98: 814–822.
Messmer BT, Albesiano E, Messmer D, Chiorazzi N . The pattern and distribution of immunoglobulin VH gene mutations in chronic lymphocytic leukemia B cells are consistent with the canonical somatic hypermutation process. Blood 2004; 103: 3490–3495.
Kröber A, Benner A, Bühler A, Döhner H, Stilgenbauer S . Multivariate survival analysis of specific VH-genes in CLL: V3–21 and V3–23 are prognostic factors independently of the VH mutation status. Blood 2002; 100: 738.
Degan M, Bomben R, Dal Bo M, Zucchetto A, Nanni P, Rupolo M et al. Analysis of IgVH gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Haematol 2004; 126: 29–42.
Pettitt AR, Sherrington PD, Allsup DJ, Matrai Z, Cawley JC, Zuzel M . Natural history of chronic lymphocytic leukaemia: current thinking. In: Hamblin T, Johnson S, Miles A (eds). The Effective Management of Chronic Lymphocytic Leukaemia. UK Key Advances in Clinical Practice Series 2004. Aesculapius Medical Press, London, UK.
Kröber A, Seiler T, Benner A, Bullinger L, Brückle E, Lichter P et al. V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood 2002; 100: 1410–1416.
Adams CL, Macleod MKL, Milner-White EJ, Aitken R, Garside P, Stott DI . Complete analysis of the B-cell response to a protein antigen, from in vivo germinal centre formation to 3-D modelling of affinity maturation. Immunology 2003; 108: 274–287.
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by the UK Leukaemia Research Fund and the Royal Liverpool and Broadgreen Hospitals Trust R&D Fund
Supplementary Information
Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu).
Supplementary information
Rights and permissions
About this article
Cite this article
Lane, B., Mensah, A., Lin, K. et al. Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic significance. Leukemia 19, 741–749 (2005). https://doi.org/10.1038/sj.leu.2403720
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403720
Keywords
This article is cited by
-
Determination of IGHV gene mutational status in chronic lymphocytic leukemia: bioinformatics advances meet clinical needs
Leukemia (2008)
-
Many human immunoglobulin heavy‐chain IGHV gene polymorphisms have been reported in error
Immunology & Cell Biology (2008)
-
ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia
Leukemia (2007)
-
Mutational status of IgVH genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?
Leukemia (2005)